Page 5,196«..1020..5,1955,1965,1975,198..5,2105,220..»

Historic stem cell surgery performed on paralyzed South Florida dog

Posted: Published on June 6th, 2013

Brando wheeled his way through the Hialeah shopping plaza parking Wednesday morning, barely able to muster more than a weak woof. The muscles around his lungs are paralyzed, the result of a skin infection that spread to a disc in his back. The infection also led to nearly 80 percent of Brandos leg muscles to atrophy, making him paralyzed from the middle of his back down. But doctors are hoping that will all change, after an innovative two-part stem cell surgery performed Wednesday at Paradise Animal Clinic in Hialeah. Its the first time the combination therapy has been performed in Florida. We know very little about [stem cell surgery] said Dr. Jose Gorostiza, a veterinary orthopedic surgeon who was involved in Wednesdays operation. But, he added, it is super cool. Brando, a 9-year-old German shepherd named after Marlon Brando, has been paralyzed since January, said his owner, Miami cardiologist Manuel Bouza. Everyone in the family was super depressed, Bouza said. We thought he was going to die, originally. As veterinarian technicians shaved Brando Wednesday and tufts of his dark brown and black fur fell beside him, the dog looked ambivalent as the morphine kicked in. Over the next four hours, … Continue reading

Comments Off on Historic stem cell surgery performed on paralyzed South Florida dog

Boulder Creek family of quadriplegic raises money for stem cell therapy

Posted: Published on June 6th, 2013

BOULDER CREEK -- Growing up, Jerry MacCallister wanted to be a naval aviator. Now, he simply wants to scratch his own nose. The 23-year-old Boulder Creek resident broke his neck in a 2009 dirt biking accident, leaving him paralyzed from the neck down. While he regained some mobility in his arms during his initial six-week hospital stay, he lost it all in 2012 when he fell into a coma for eight days. Since then, he's slowly relearned how to breathe and talk, but still can't move his body. After years of working with countless doctors and physical therapists without seeing significant improvement, MacCallister will undergo stem cell therapy this summer in Thailand. Looking to chip away at $40,000 in travel and medical procedures, his family's hosting a spaghetti feed Saturday at the Boulder Creek Fire Department. "It's basically his last hope," said his mother, Katie MacCallister. Her son will receive eight stem cell injections derived from an umbilical cord during the course of 40 days, as well as physical, aquatic and occupational therapy and acupuncture. It typically takes up to nine months to see results. Beike Biotechnology, a company that specializes in adult stem cell therapy, will oversee the treatment. … Continue reading

Comments Off on Boulder Creek family of quadriplegic raises money for stem cell therapy

Stem Cell Therapy Cures Type 1 Diabetes in Mice

Posted: Published on June 6th, 2013

Whether the new approach would work in humans is unknown, experts say WebMD News from HealthDay By Serena Gordon HealthDay Reporter WEDNESDAY, June 5 (HealthDay News) -- Using an immune-suppressing medication and adult stem cells from healthy donors, researchers say they were able to cure type 1 diabetes in mice. "This is a whole new concept," said the study's senior author, Habib Zaghouani, a professor of microbiology and immunology, child health and neurology at the University of Missouri School of Medicine in Columbia, Mo. In the midst of their laboratory research, something unanticipated occurred. The researchers expected that the adult stem cells would turn into functioning beta cells (cells that produce insulin). Instead, the stem cells turned into endothelial cells that generated the development of new blood vessels to supply existing beta cells with the nourishment they needed to regenerate and thrive. "I believe that beta cells are important, but for curing this disease, we have to restore the [blood vessels]," Zaghouani said. It's much too early to know if this novel combination would work in humans. But the findings could stimulate new avenues of research, another expert says. "This is a theme we've seen a few times recently. Beta … Continue reading

Comments Off on Stem Cell Therapy Cures Type 1 Diabetes in Mice

Revlimid Gains, Celgene Loses

Posted: Published on June 5th, 2013

Celgene (NASDAQ: CELG) announced good news today about its blockbuster drug Revlimid. Did the stock jump as a result? Nope. Shares actually fell by more than 4%. Here's what happened. Good news The U.S. Food and Drug Administration approved Revlimid as atreatment for patients with mantle cell lymphoma whose disease has relapsed or progressed after two prior therapies, one of which included Velcade, a drug marketed by Johnson & Johnsonand Takeda. Revlimid was previously approved in the U.S. as a second-line treatment for multiple myeloma and for treating myelodisplastic syndromes. Mantle cell lymphoma is a type of non-Hodgkin's lymphoma that is very rare, affecting only around 15,000 patients in the United States. Although a few treatments for the disease are available, Dr.Andre Goy with the Hackensack University Medical Center says that "there remains a tremendous unmet need" for patients who have not responded satisfactorily after previous treatments. FDA approval for Revlimid makes it the first oral therapy for mantle cell lymphoma. ... but old news? You might think that approval of a new indication would cause some excitement for investors. So why did Celgene's shares fall? One reason is that the market most likely already baked this approval into the … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Revlimid Gains, Celgene Loses

U.S. Food and Drug Administration Approves REVLIMID® (lenalidomide) for the Treatment of Patients with Relapsed or …

Posted: Published on June 5th, 2013

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (CELG) today announced the U.S. Food and Drug Administration (FDA) has approved the companys supplemental new drug application (sNDA) for REVLIMID (lenalidomide) for the treatment of patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib. There remains a tremendous unmet need for patients with previously-treated mantle cell lymphoma, said Andre Goy, M.D., M.S., Chairman and Director and Chief of Lymphoma, John Theurer Cancer Center at Hackensack UMC and Chief Science Officer and Director of Research and Innovation at Regional Cancer Care Associates, LLC. The approval of lenalidomide delivers a new option, and the first oral therapy in this area of lymphoma. The approval was based on the results of MCL-001, a phase II, multi-center, single arm, open label study evaluating lenalidomide in 134 patients with MCL who had received prior treatment with rituximab, cyclophosphamide, an anthracycline (or mitoxantrone), and bortezomib alone or in combination. Patients were required to have documented refractory disease (defined as without any response of partial response or better during treatment with bortezomib or a bortezomib-containing regimen), or relapsed disease (defined as progression within one year after treatment with bortezomib … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on U.S. Food and Drug Administration Approves REVLIMID® (lenalidomide) for the Treatment of Patients with Relapsed or …

AVEO To Slash Jobs, PSTI, RIGL Hit Hard, STEM, NVIV, RGDX Fatten Purse

Posted: Published on June 5th, 2013

(RTTNews.com) - In an effort to extend its cash runway for at least two years, AVEO Oncology ( AVEO ) on Tuesday announced a strategic restructuring that will reportedly include slashing 62% of its workforce. More details about the restructuring will be revealed during a conference call that will be hosted at 8:30 a.m. ET on Wednesday, June 5. Last month, an FDA panel voted 13 to 1 against approving AVEO's Tivozanib for advanced renal cell carcinoma. AVEO's partner Astellas has also decided not to proceed with a European filing for Tivozanib or financially support future clinical trials in renal cell carcinoma. AVEO closed Tuesday's trading at $2.49, down 2.35%. In after-hours, the stock gained 1.61% to $2.53. Bristol-Myers Squibb Co.'s ( BMY ) and AstraZeneca's ( AZN ) Biologics License Application for Metreleptin, an investigational agent for treatment of metabolic disorders associated with rare forms of lipodystrophy has been accepted and granted a Priority Review designation by the FDA. The BLA for Metreleptin was submitted on a rolling basis - with the submission initiated in December 2010 and completed in April 2012. InVivo Therapeutics Holdings Corp. ( NVIV ), which trades on the over the counter Bulletin Board, touched … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on AVEO To Slash Jobs, PSTI, RIGL Hit Hard, STEM, NVIV, RGDX Fatten Purse

Scientists Find Stem Cells in Liposuctioned Fat

Posted: Published on June 5th, 2013

A donor egg is held by a pipette prior to nuclear extraction. Scientists have found a new source of potentially useful stem cells in liposuctioned fat tissue. The stem cells discovered in adipose, or fat tissue, are considered "pluripotent," meaning they can be differentiated into essentially any type of body cell, making them potentially useful for a variety of medical uses. Researchers believe that pluripotent stem cells will be used to treat neurological disorders such as Parkinson's and Alzheimer's Diseases. Until the most recent discovery, made by University of CaliforniaLos Angeles researcher Gregorio Chazenbalk and described in the journal PLOS ONE, the two main types of pluripotent stem cells were embryonic and induced pluripotent cells, which are made by re-engineering skin cells. Several years ago, scientists discovered stem cells in fat tissue that could not be differentiated into other types of cells. According to Chazenbalk, the newly-discovered pluripotent stem cells that exist in fat tissue are known as Muse-AT cells and are particularly stress-resistant, meaning they would be useful for treating traumatic injuries. [READ: Stem Cell Therapy Cures Type 1 Diabetes in Mice] "This population of cells lies dormant in the fat tissue until it is subjected to very harsh … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Scientists Find Stem Cells in Liposuctioned Fat

World's First Human Embryonic Stem Cell Trial for Spinal Cord Injury: Kate Sharify's Story – Video

Posted: Published on June 5th, 2013

World's First Human Embryonic Stem Cell Trial for Spinal Cord Injury: Kate Sharify's Story Visit: http://www.uctv.tv/) Katie Sharify was one of five people with spinal cord injuries to participate in the world's first clinical trial testing human ... By: UCtelevision … Continue reading

Comments Off on World's First Human Embryonic Stem Cell Trial for Spinal Cord Injury: Kate Sharify's Story – Video

UCLA Scientists Isolate and Characterize New Population of Stress-Resistant Pluripotent Stem Cells in Fat Tissue …

Posted: Published on June 5th, 2013

Newswise Researchers from the UCLA Department of Obstetrics and Gynecology have isolated a new population of primitive, stress-resistant human pluripotent stem cells easily derived from fat tissue that are able to differentiate into virtually every cell type in the human body without genetic modification. The cells, called Multi-lineage Stress-Enduring (Muse-AT) stem cells from fat, or adipose, tissue, were discovered by scientific accident when a piece of equipment failed in the lab, killing all the stem cells in the experiment except for the Muse-AT cells. The research team further discovered that not only are Muse-AT cells able to survive severe stress, they may even be activated by it, said study senior author Gregorio Chazenbalk, an associate researcher with UCLA Obstetrics and Gynecology. These pluripotent cells, isolated from fat tissue removed during liposuction, expressed many embryonic stem cell markers and were able to differentiate into muscle, bone, fat, cardiac, neuronal and liver cells. An examination of their genetic characteristics confirmed their specialized functions, as well as their capacity to regenerate tissue when transplanted back into the body following their awakening. This population of cells lies dormant in the fat tissue until it is subjected to very harsh conditions. These cells can survive … Continue reading

Comments Off on UCLA Scientists Isolate and Characterize New Population of Stress-Resistant Pluripotent Stem Cells in Fat Tissue …

Scientists unexpectedly discover stress-resistant stem cells in fat tissue removed during liposuction

Posted: Published on June 5th, 2013

June 5, 2013 Researchers from the UCLA Department of Obstetrics and Gynecology have isolated a new population of primitive, stress-resistant human pluripotent stem cells easily derived from fat tissue that are able to differentiate into virtually every cell type in the human body without genetic modification. The cells, called Multi-lineage Stress-Enduring (Muse-AT) stem cells from fat, or adipose, tissue, were discovered by "scientific accident" when a piece of equipment failed in the lab, killing all the stem cells in the experiment except for the Muse-AT cells. The research team further discovered that not only are Muse-AT cells able to survive severe stress, they may even be activated by it, said study senior author Gregorio Chazenbalk, an associate researcher with UCLA Obstetrics and Gynecology. These pluripotent cells, isolated from fat tissue removed during liposuction, expressed many embryonic stem cell markers and were able to differentiate into muscle, bone, fat, cardiac, neuronal and liver cells. An examination of their genetic characteristics confirmed their specialized functions, as well as their capacity to regenerate tissue when transplanted back into the body following their "awakening." "This population of cells lies dormant in the fat tissue until it is subjected to very harsh conditions. These cells … Continue reading

Comments Off on Scientists unexpectedly discover stress-resistant stem cells in fat tissue removed during liposuction

Page 5,196«..1020..5,1955,1965,1975,198..5,2105,220..»